IMNM - Immunome, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$36.20
DETAILS
HIGH:
$40.00
LOW:
$32.00
MEDIAN:
$36.00
CONSENSUS:
$36.20
UPSIDE:
67.13%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Greenblatt | 10,100 | $220,887 | 0.0% | -- | UNCHANGED |
| Wood | 0 | $0 | -- | -75,000 | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-15 | BIENAIME JEAN JACQUES | director | BUY | 5,000 | $20.70 | $104K |
| 2026-04-02 | Higgins Jack | officer: Chief Scientific Officer | SELL | 9,438 | $21.64 | $204K |
| 2026-04-02 | Rosett Max | officer: Chief Financial Officer | M-Exempt | 31,848 | $1.05 | $33K |
| 2026-04-02 | Rosett Max | officer: Chief Financial Officer | SELL | 63,656 | $21.91 | $1.4M |
| 2026-04-02 | Rosett Max | officer: Chief Financial Officer | SELL | 1,344 | $22.48 | $30K |
| 2026-04-02 | Rosett Max | officer: Chief Financial Officer | M-Exempt | 39,713 | $1.35 | $54K |
| 2026-03-30 | Higgins Jack | officer: Chief Scientific Officer | G-Gift | 6,291 | -- | -- |
| 2026-03-27 | SIEGALL CLAY B | director, officer: President and CEO | BUY | 25,450 | $19.67 | $501K |
| 2026-03-20 | WAGENHEIM PHILIP | director | SELL | 36,800 | $20.47 | $753K |
| 2026-03-23 | WAGENHEIM PHILIP | director | SELL | 28,200 | $20.65 | $582K |
| 2026-03-10 | BIENAIME JEAN JACQUES | director | BUY | 1,000 | $22.12 | $22K |
| 2026-03-11 | BIENAIME JEAN JACQUES | director | BUY | 1,000 | $21.55 | $22K |
| 2025-12-30 | SIEGALL CLAY B | director, officer: President and CEO | BUY | 4,729 | $21.15 | $100K |
| 2025-12-22 | Barchas Isaac | director | SELL | 371,949 | $21.72 | $8.1M |
| 2025-12-22 | Barchas Isaac | director | SELL | 11,251 | $22.34 | $251K |
| 2025-12-19 | SIEGALL CLAY B | director, officer: President and CEO | BUY | 7,278 | $20.48 | $149K |
| 2025-12-19 | SIEGALL CLAY B | director, officer: President and CEO | G-Gift | 200,000 | -- | -- |
| 2025-12-19 | Higgins Jack | officer: Chief Scientific Officer | G-Gift | 1,000 | -- | -- |
| 2025-12-19 | Tsai Philip | officer: Chief Technical Officer | BUY | 10,000 | $20.49 | $205K |
| 2025-12-18 | SIEGALL CLAY B | director, officer: President and CEO | BUY | 46,511 | $21.50 | $1000K |
| 2025-09-10 | Higgins Jack | officer: Chief Scientific Officer | M-Exempt | 22,000 | $1.35 | $30K |
| 2025-07-29 | Higgins Jack | officer: Chief Scientific Officer | A-Award | 196,000 | $10.60 | $2.1M |
| 2025-07-29 | SIEGALL CLAY B | director, officer: President and CEO | A-Award | 800,000 | $10.60 | $8.5M |
| 2025-07-29 | Lechleider Robert | officer: Chief Medical Officer | A-Award | 242,000 | $10.60 | $2.6M |
| 2025-07-29 | Tsai Philip | officer: Chief Technical Officer | A-Award | 190,000 | $10.60 | $2.0M |